Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-05 to 2023-06-27
Current total value of award: $2734.96
Description: 4561201707!NEXPLANON 68 MG IMPLANTS